KEGG   COMPOUND: C03378
Entry
C03378                      Compound                               
Name
Coagulation factor VIIa
Sequence
(Light chain)
ANAFLEELRP GSLERECKEE QCSFEEAREI FKDAERTKLF WISYSDGDQC ASSPCQNGGS
CKDQLQSYIC FCLPAFEGRN CETHKDDQLI CVNENGGCEQ YCSDHTGTKR SCRCHEGYSL
LADGVSCTPT VEYPCGKIPI LEKRNASKPQ GR
(Heavy chain)
IVGGKVCPKG ECPWQVLLLV NGAQLCGGTL INTIWVVSAA HCFDKIKNWR NLIAVLGEHD
LSEHDGDEQS RRVAQVIIPS TYVPGTTNHD IALLRLHQPV VLTDHVVPLC LPERTFSERT
LAFVRFSLVS GWGQLLDRGA TALELMVLNV PRLMTQDCLQ QSRKVGDSPN ITEYMFCAGY
SDGSKDSCKG DSGGPHATHY RGTWYLTGIV SWGQGCATVG HFGVYTRVSQ YIEWLQKLMR
SEPRPGVLLR APFP
(Disulfide bridge: L135-H110)
  Organism
Homo sapiens [HSA:2155]
  Type
Peptide
Remark
Same as: D00172
Pathway
map04610  Complement and coagulation cascades
Network
nt06514  Coagulation cascade
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 B BLOOD AND BLOOD FORMING ORGANS
  B02 ANTIHEMORRHAGICS
   B02B VITAMIN K AND OTHER HEMOSTATICS
    B02BD Blood coagulation factors
     B02BD05 Coagulation factor VII
      D00172  Eptacog alfa (INN) <JP/US>
     B02BD08 Coagulation factor VIIa
      D00172  Eptacog alfa (INN) <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  63  Biological preparations
   634  Human blood preparations
    6343  Plasma preparations
     D00172  Eptacog alfa (INN); Eptacog alfa (activated) (genetical recombination) (JAN)
Drug groups [BR:br08330]
 Blood modifier agent
  DG02016  Hemostatics
   DG02014  Blood coagulation accelerant
    DG02013  Blood coagulation factor
     DG00172  Blood coagulation factor VII
      D00172  Eptacog alfa
Target-based classification of drugs [BR:br08310]
 Peptidases and inhibitors
  Serine peptidases
   Chymotrypsin family
    F7a
     D00172  Eptacog alfa (INN) <JP/US>
New drug approvals in the USA [br08319.html]
 Cellular and gene therapy products
  D00172
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D00172
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D00172
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D00172
Other DBs
PubChem: 6213
ChEBI: 3777
LinkDB

» Japanese version

KEGG   Homo sapiens (human): 2152
Entry
2152              CDS       T01001                                 
Symbol
F3, CD142, TF, TFA
Name
(RefSeq) coagulation factor III, tissue factor
  KO
K03901  coagulation factor III (tissue factor)
Organism
hsa  Homo sapiens (human)
Pathway
hsa04610  Complement and coagulation cascades
hsa04933  AGE-RAGE signaling pathway in diabetic complications
Network
nt06514  Coagulation cascade
  Element
N01503  Extrinsic pathway of coagulation cascade, F7 activation
N01510  Common pathway of coagulation cascade, F10 activation
Drug target
Tifacogin: D06142
Tisotumab: D11813
Tisotumab vedotin: D11814<JP/US>
Brite
KEGG Orthology (KO) [BR:hsa00001]
 09150 Organismal Systems
  09151 Immune system
   04610 Complement and coagulation cascades
    2152 (F3)
 09160 Human Diseases
  09167 Endocrine and metabolic disease
   04933 AGE-RAGE signaling pathway in diabetic complications
    2152 (F3)
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04090 CD molecules [BR:hsa04090]
    2152 (F3)
   00537 Glycosylphosphatidylinositol (GPI)-anchored proteins [BR:hsa00537]
    2152 (F3)
CD molecules [BR:hsa04090]
 Proteins
  2152 (F3)
Glycosylphosphatidylinositol (GPI)-anchored proteins [BR:hsa00537]
 Others
  2152 (F3)
SSDB
Motif
Pfam: Tissue_fac Interfer-bind KIAA1549 Baculo_11_kDa GBS104-like_Ig
Other DBs
NCBI-GeneID: 2152
NCBI-ProteinID: NP_001984
OMIM: 134390
HGNC: 3541
Ensembl: ENSG00000117525
UniProt: P13726
Structure
LinkDB
Position
1:complement(94529173..94541759)
AA seq 295 aa
METPAWPRVPRPETAVARTLLLGWVFAQVAGASGTTNTVAAYNLTWKSTNFKTILEWEPK
PVNQVYTVQISTKSGDWKSKCFYTTDTECDLTDEIVKDVKQTYLARVFSYPAGNVESTGS
AGEPLYENSPEFTPYLETNLGQPTIQSFEQVGTKVNVTVEDERTLVRRNNTFLSLRDVFG
KDLIYTLYYWKSSSSGKKTAKTNTNEFLIDVDKGENYCFSVQAVIPSRTVNRKSTDSPVE
CMGQEKGEFREIFYIIGAVVFVVIILVIILAISLHKCRKAGVGQSWKENSPLNVS
NT seq 888 nt   +upstreamnt  +downstreamnt
atggagacccctgcctggccccgggtcccgcgccccgagaccgccgtcgctcggacgctc
ctgctcggctgggtcttcgcccaggtggccggcgcttcaggcactacaaatactgtggca
gcatataatttaacttggaaatcaactaatttcaagacaattttggagtgggaacccaaa
cccgtcaatcaagtctacactgttcaaataagcactaagtcaggagattggaaaagcaaa
tgcttttacacaacagacacagagtgtgacctcaccgacgagattgtgaaggatgtgaag
cagacgtacttggcacgggtcttctcctacccggcagggaatgtggagagcaccggttct
gctggggagcctctgtatgagaactccccagagttcacaccttacctggagacaaacctc
ggacagccaacaattcagagttttgaacaggtgggaacaaaagtgaatgtgaccgtagaa
gatgaacggactttagtcagaaggaacaacactttcctaagcctccgggatgtttttggc
aaggacttaatttatacactttattattggaaatcttcaagttcaggaaagaaaacagcc
aaaacaaacactaatgagtttttgattgatgtggataaaggagaaaactactgtttcagt
gttcaagcagtgattccctcccgaacagttaaccggaagagtacagacagcccggtagag
tgtatgggccaggagaaaggggaattcagagaaatattctacatcattggagctgtggta
tttgtggtcatcatccttgtcatcatcctggctatatctctacacaagtgtagaaaggca
ggagtggggcagagctggaaggagaactccccactgaatgtttcataa

DBGET integrated database retrieval system